Применение стволовых клеток для улучшения восстановления после инсульта

 

37.    Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phe- notype of other cells by spontaneous cell fusion. Nature 2002; 416:542-5.

 

38.    Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J,Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447:725-9.

 

39.    Chen J, Sanberg PR, Li Yet al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32:2682-8.

 

40.    Nagai A, Kim WK, Lee HJ et al. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS ONE [Electronic ResourceI 2007; 2:el272.

 

41.    Sokolova I, Fedotova O, Zin'Kova N, Kruglyakov P, PolyntsevD. Effect of mesenchymal stem cell transplantation on cognitive function in rats with ischaemic stroke. Bull Exp Biol Med 2006; 2:511-4.

 

42.    Borlongan CV, Evans A, Yu G, Hess DC. Limitations of intravenous human bone marrow CD 1331 cell grafts in stroke rats. Brain Res 2005; 1048:116-22.

 

43.    Guo Y, Lubbert M, Engelhardt M. CD34_ hematopoietic stem cells: current concepts and controversies. Stem Cells 2003; 21:15-20.

 

44.    Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103:2776-9.

 

45.    Dunac A, Frelin C, Popolo-Blondeau M, Chatel M, Mahagne M, Philip P. Neurological and functional recovery in human stroke are associated with peripheral blood CD341 cell mobilization. ] Neurol 2007; 254:327-32.

 

46.     Hennemann B, Ickenstein G, Sauerbruch S et al. Mobilization of CD341 hematopoietic cells, colony-forming cells and long-term cul- ture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy 2008; 10:303-11.

 

47.    Taguchi A, Matsuyama T, Moriwaki H et al. Circulating CD34-positi- ve cells provide an index of cerebrovascular function. Circulation 2004; 109:2972-5.

 

48.     Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111:2981-7.

 

49.    Jung KH, Chu K, Lee STet al. Identification of neuronal outgrowth cells from peripheral blood of stroke patients. Ann Neurol 2008; 63:312-22.

 

50.    Jin K.MaoXO, SunY, Xie L, GreenbergDA. Stem cell factor stimulates neurogenesis in vitro and in vivo. / Clin Invest 2002; 110:311 -9.

 

51.    Brines ML, Ghezzi P, Keenan S et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97:10526-31.

 

52.    Gibson CL, Bath PM,Murphy SP. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005; 25:431-9.

 

53.    Schabitz WR, Kruger C, Pitzer С et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 2008; 28:29-43.

 

54.    Vincent VA, Robinson CC, Simsek D, Murphy GM. Macrophage colony stimulating factor preventsNMDA-induced neuronal death in hippocampal organotypic cultures. ] Neurochem 2002; 82:1388-97.

 

55.    Schabitz WR, Kollmar R, Schweninger M et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003; 34:745-51.

 

56.    Kollmar R, Henninger N, Urbanek C, Schabitz W, Schneider A, Schwab S. Effects of G-CSF in combination with rt-PA after experimental thromboembolic stroke. Akt Neurol 2004; 31:S1,V88.

 

57.    Kollmar R, Henninger N, Urbanek C, Schwab S. G-CSF and rt-PA for the treatment of experimental embolic stroke. Cerebrovasc Dis 2007; 23(Suppl. 2):23.

 

58.    ShyuWC, Lin SZ, Yang HI et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004; 110:1847-54.

 

59.    Lee ST, Chu K, Jung KH et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 2005; 1058:120-8.

 

60.    Sehara Y, Hayashi T, Deguchi К et al. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res 2007; 1151:142-9.

 

61.    Schneider A, Kruger C, Steigleder T et al. The hematopoietic factor G- CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. / Clin Invest 2005; 115:2083-98.

 

62.    Taguchi A,Wen Z, Myojin К et al. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine modelwa. Eur J Neurosci 2007; 26:126-33.

 

63.    Zhao LR, Berra HH, Duan WM et al. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 2007; 38:2804-11.

 

64.    Matchett GA, Calinisan JB, Matchett GC, Martin RD, Zhang JH. The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res 2007; 1136:200-7.

 

65.     Komine-KobayashiM, Zhang N, LiuMet al. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 2006; 26:402-13.

 

66.    GibsonCL, JonesNC,PriorMJ,BathPM,MurphySP.G-CSF suppresses edema formation and reduces interleuldn-lbeta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 2005; 64:763-9.

 

67.    Jacobs KM, Donoghue JP. Reshaping the cortical motor map by unmasking latent intracortical connections. Science 1991; 251:944-7.

 

68.     Carmichael ST, Chesselet MF. Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult. JNeurosci 2002; 22:6062-70.

 

69.    Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361:31-9.

 

70.    Pantano P, Baron JC, Samson Y, Bousser MG, Derouesne C, Comar D. Crossed cerebellar diaschisis. Further studies. Brain 1986; 109:677-94.

 

71.    Jin K, Minami M, Lan JQ et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci USA 2001; 98:4710-5.

 

72.    Vaynman S, Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabil Neural Repair 2005; 19:283-95.

 

73.    Sprigg N, Bath P. Pharmacological enhancement of recovery from stroke. Curr Med Literature Stroke Rev 2005; 8:33-9.

 

74.    Taguchi A, Soma T, Tanaka H et al. Administration of CD341 cells after stroke enhances neurogenesis via angiogenesis in a mouse model. I Clin Invest 2004; 114:330-8.

 

75.    Ishibashi S, Sakaguchi M, Kuroiwa T et al. Human neural stem/pro- genitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neu- rosci Res 2004; 78:215-23.

 

76.    Kelly S, Bliss TM, Shah AK et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004; 101:11839-44.

 

77.    Nystedt I, Makinen S, Laine J, Jolkkonen J. Human cord blood CD341 cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol Exp 2006; 66:293-300.

 

78.    Makinen S, Kekarainen T, Nystedt J et al. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res 2006; 1123:207-15.

 

79.    Vendrame M, Gemma C, de Mesquita D et al. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005; 14:595-604.

 

80.    Lee SH, Kim YJ, Lee KM, Ryu S, Yoon BW. Ischemic preconditioning enhances neurogenesis in the subventricular zone. Neuroscience 2007; 146:1020-31.

 

81.    Ray J, Gage FH. Differential properties of adult rat and mouse brainde- rived neural stem/progenitor cells. Mol Cell Neurosci 2006; 31:560-73.

 

82.     YagitaY,KitagawaK,OhtsukiTet al.Neurogenesis byprogenitor cells in the ischemic adult rat hippocampus. Stroke 2001; 32:1890-6.

 

83.    Minger S, Ekonomou A, Carta E, Chinoy A, Perry R, Ballard C. Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007; 2:69-74.

 

84.     Bogousslavsky J.Victor S, Salinas E et al. Fiblast (Trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial. Cerebrovasc Dis 2002; 14:239-51.

 

85.    Lees KR, Muir KW. Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst Rev 2003; CD001244.

 

86.    Zhang R, Zhang Z, Wang L et al. Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. / Cereb Blood Flow Metab 2004; 24:441-8.

 

87.    Sinden JD. ReNeuron group pic. Regen Med 2006; 1:143-7.

 

88.    Pollock K, Stroemer P, Patel S et al.Aconditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 2006; 199:143-55.

 

89.    Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, ShineHD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002; 297:1299.

 

90.    Wagers AJ, Sherwood RI, Christensen JL,Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002; 297:2256-9.

 

91.    Vendrame M, Cassady J, Newcomb J et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004; 35:2390-5.

 

92.    Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34( 1) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001; 97:3075-85.

 

93.    Xiao J, Nan Z, Motooka Y, Low WC. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 2005; 14:722-33.

 

94.    Chen J, Li Y, Wang L et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32:1005-11.

 

95.    Hoehn M, Kustermann E, Blunk J et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 99:16267-72.

 

96.     Jendelova P, Herynek V, Urdzikova L et al. Magnetic resonance tracking of human CD34 progenitor cells separated by means of immu- nomagnetic selection and transplanted into injured rat brain. Cell Transplant 2005; 14:173-82.

 

97.    Wang Y, Deng Y, Zhou GQ. SDF-lalpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 2008; 1195:104-12.

 

98.     Kondziolka D, Wechsler L, Goldstein S et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55:565-9.

 

99.    Nelson PT, Kondziolka D, Wechsler L et al. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol 2002; 160:1201-6.

 

100.         Kleppner             SR, Robinson KA, Trojanowski JQ, Lee VM. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain./ Comp Neurol 1995; 357:618-32.

 

 

101.                   KondziolkaD,              Steinberg GK,Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005; 103:38-45.

 

102. 102.Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 2005; 20:101-7.

 

103. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57:874-82.

 

104. De Keyser J. Autologous mesenchymal stem cell transplantation in stroke patients [comment]. Ann Neurol 2005; 58:653-4; author reply 654-5.

 

105. Bang OY. An apology: inadvertent error in our article published in June 2005 issue of the Ann Neurol (Ann Neurol 2005; 57:874-882). Ann Neurol 2005; 58:659.

 

106. Sprigg N, Bath PM, Zhao L et al. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006; 37:2979-83.

 

107. 107.Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colonystimula- ting factor for acute ischemic stroke: a randomized controlled trial. CMAJ 2006; 174:927-33.

 

108. Zhang JJ, Deng M, Zhang Y, Sui W, Wang L, Sun A. A short-term assessment of Recombinant Granulocyte-Stimulating factor (RHGCSF) in treatment of acute cerebral infarction. Cerebrovasc Dis 2006; 21(Suppl. 4):143.

 

109. Bath PM, Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev 2006; 3:CD005207.

 

110. Cavallaro AM, Lilleby K, Majolino I et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000; 25:85-9.

 

111.  lll.Sohngen D,Wienen S, SieblerMet al. Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination. Bone Marrow Transplant 1998; 22:1087-90.

 

112. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research .JAMA 2005; 294:218-28.

 

113.  Anonymous. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30:2752-8.

 

114. Lee ST, Chu K, Jung KH et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008; 131:616-29.

 

115. Kim JM, Lee ST, Chu К et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007; 1183:43-50.

 

116. Jin K, Sun Y, Xie L et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis 2005; 18:366-74.

 

117.                                      BorlonganCV,Hadman   M, SanbergCD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004; 35:2385-9.

 

118.  Modo      M.Mellodew K, CashDet al.Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 2004; 21:311-7.

 

119.   Martin    PA, Coveney C, Kraft A, Brown N, Bath P. Commercial development of stem cell technology: Lessons fromthe past, strategies for the future. Regen Med 2006; 1:801-7.